Other Species / Isoforms
  LIME1 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S54-p
QRARLQGsATAAEAs
0 2
LIME1 (human) QRARLQGsATAAEAs S54-p
LIME1 (mouse) QQTGLQDSLVPVEMP S46
S61-p
sATAAEAsLLRRtHL
Upstream
0 3
Treatment
  • ischemia
LIME1 (human) sATAAEAsLLRRtHL S61-p
LIME1 (mouse) SLVPVEMPLLRQTHL P53
T66-p
EAsLLRRtHLCsLSk
0 1
LIME1 (human) EAsLLRRtHLCsLSk T66-p
LIME1 (mouse) EMPLLRQTHLCSLSK T58
S70-p
LRRtHLCsLSksDTR
0 2
LIME1 (human) LRRtHLCsLSksDTR S70-p
LIME1 (mouse) LRQTHLCSLSKsDTR S62
K73-ub
tHLCsLSksDTRLHE
0 3
LIME1 (human) tHLCsLSksDTRLHE K73-ub
LIME1 (mouse) THLCSLSKsDTRLHE K65
S74-p
HLCsLSksDTRLHEL
Upstream
0 3
Treatment
  • ischemia
LIME1 (human) HLCsLSksDTRLHEL S74-p
LIME1 (mouse) HLCSLSKsDTRLHEL S66-p
S87-p
ELHRGPRssRALRPA
0 1
LIME1 (human) ELHRGPRssRALRPA S87-p
LIME1 (mouse) ELHRGPRSSIAPRPA S79
S88-p
LHRGPRssRALRPAs
0 2
LIME1 (human) LHRGPRssRALRPAs S88-p
LIME1 (mouse) LHRGPRSSIAPRPAS S80
S95-p
sRALRPAsMDLLRPH
Upstream
0 7
Treatment
  • ischemia
LIME1 (human) sRALRPAsMDLLRPH S95-p
LIME1 (mouse) SIAPRPASMDLLHPR S87
Y145-p
CAGLEATySNVGLAA
2 2
LIME1 (human) CAGLEATySNVGLAA Y145-p
LIME1 (mouse) STSSEATySNVGLAA Y137-p
Y167-p
ASPVVAEyARVQKRK
Downstream
1 12
Effects on Modified Protein
  • molecular association, regulation
LIME1 (human) ASPVVAEyARVQKRK Y167-p
LIME1 (mouse) RLGPGAEyACIQKHK Y175-p
Y200-p
AAQVDVLysRVCkPk
Downstream
1 92
Effects on Modified Protein
  • molecular association, regulation
LIME1 (human) AAQVDVLysRVCkPk Y200-p
LIME1 (mouse) ATQMDVLySRVCKPK Y207-p
S201-p
AQVDVLysRVCkPkR
0 3
LIME1 (human) AQVDVLysRVCkPkR S201-p
LIME1 (mouse) TQMDVLySRVCKPKR S208
K205-ub
VLysRVCkPkRRDPG
0 1
LIME1 (human) VLysRVCkPkRRDPG K205-ub
LIME1 (mouse) VLySRVCKPKRRDPR K212
K207-ub
ysRVCkPkRRDPGPT
0 1
LIME1 (human) ysRVCkPkRRDPGPT K207-ub
LIME1 (mouse) ySRVCKPKRRDPRPV K214
Y235-p
ALAGDLAyQtLPLRA
3 18
LIME1 (human) ALAGDLAyQtLPLRA Y235-p
LIME1 (mouse) PLGSDVEyEAINLRG Y242-p
T237-p
AGDLAyQtLPLRALD
0 1
LIME1 (human) AGDLAyQtLPLRALD T237-p
LIME1 (mouse) GSDVEyEAINLRGQD A244
Y254-p
SGPLENVyEsIRELG
Downstream
3 16
Effects on Modified Protein
  • molecular association, regulation
LIME1 (human) SGPLENVyEsIRELG Y254-p
LIME1 (mouse) QGPLENVyESIKEMG Y261-p
S256-p
PLENVyEsIRELGDP
0 2
LIME1 (human) PLENVyEsIRELGDP S256-p
LIME1 (mouse) PLENVyESIKEMGL_ S263
T274-p
SSTCGAGtPPASSCP
Upstream
0 1
Treatment
  • ischemia
LIME1 (human) SSTCGAGtPPASSCP T274-p
LIME1 (mouse) gap -
R288-m1
PSLGRGWrPLPAsLP
0 1
LIME1 (human) PSLGRGWrPLPAsLP R288-m1
LIME1 (mouse) gap -
S293-p
GWrPLPAsLP_____
Upstream
0 1
Treatment
  • ischemia
LIME1 (human) GWrPLPAsLP_____ S293-p
LIME1 (mouse) gap -